Serum interferon gamma-induced protein 10 in obese non-diabetic patients with metabolic dysfunction-associated steatotic liver disease
Serum IP-10 is significantly elevated in obese non-diabetic MASLD patients and strongly associated with metabolic derangements, insulin resistance, and hepatic steatosis. These findings suggest that IP-10 may serve as a promising early non-invasive risk stratification tool or an adjunctive biomarker for MASLD.
Authors
- Olfat Fawzy (ORCID: https://orcid.org/0000-0002-4317-9771)
- Safaa A. Abd El-Aziz
- Marwan A. Ibrahim (ORCID: https://orcid.org/0000-0002-3012-9118)
- Emad Gamil Khidr (ORCID: https://orcid.org/0000-0002-7395-234X)
- Mohamed Fouad (ORCID: https://orcid.org/0009-0009-8355-8301)
Institutions
- Al-Azhar University (EG)
- Al-Azhar University (ID)
- Al Azhar University (QA)
Publication Details
- Journal
- Scandinavian Journal of Gastroenterology
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1080/00365521.2025.2603580
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35